The Intelligence Layer

Every paper, protocol, and experience.
One terminal.

This AI is grounded in 89 academic papers on ibogaine, 450+ articles from practitioners on pre-treatment and integration, and the Bwiti protocols Eyeboga partners use. It's for pre-journey prep, medical screening, prescription taper, intention work, contraindications, and post-journey integration, somatic check-ins, journaling prompts, pattern recognition.

Not a medical professional. Not a therapist. Not a sales bot.

What the terminal has read.
And what it won't say.

The AI is grounded in real sources, academic, practitioner, protocol, and has explicit limits about what it will and won't do with them.

Peer-reviewed and clinical.

Systematic reviews, pharmacology, safety, PTSD and veteran applications. Updated quarterly. Includes the Stanford and Columbia working groups, the longer follow-up cohorts, and the New Zealand observational studies that anchor most of the durability claims in the field.

Mash, D.C. - 2018 - Ann. N.Y. Acad. Sci.

“QTc prolongation is the dominant cardiac signal; magnesium and potassium correction substantially reduces the event rate.”

View source

Brown, T.K. - 2017 - Am. J. Drug Alcohol Abuse

“Single-dose ibogaine produced sustained reductions in opioid withdrawal severity in a small open-label cohort.”

View source

Davis, A.K. et al. - 2020 - Chronic Stress

“Special Operations Forces veterans reported durable affective change at thirty days post-administration.”

View source

Last updated · 2026-04-30

Two decades of field notes.

Anders Beatty's two-decade archive on pre-treatment and integration. Verified by the practitioner. Includes the dream archive, the taper letter templates, the week-by-week field notes, and the conflict-of-interest disclosures the archive is built on top of.

The taper letter, and who it is actually forPre-treatment
The letter is written for the prescribing clinician, not the seeker. Names the medicine, the half-life, the proposed off-drug window.
Week three is where the work either starts or quietly endsIntegration
The afterglow softens around day eight. What comes next decides whether the dose held or whether the seeker returns to baseline.
When the dreams turn sharp at the two-month markIntegration
A modal pattern between weeks four and twelve. Journaling on waking, before the phone, is the single most reliable intervention.

Verified by the practitioner · Anders Beatty

From the partners themselves.

Admission criteria, detox protocols, prescription-medication taper letters, journaling guidelines, intake forms. Reviewed against current clinical guidance and refreshed with each partner. The terminal is allowed to quote from them; it isn't allowed to substitute its judgment for the partner's.

Detox Protocol · 10-day pre-journeyvia Exclusive Ibogaine
Journaling Guidelines · daily + weeklyvia Ibogainecoaching
Prescription Medication Taper · SSRI/SNRIvia Ambio Life Sciences
Admission Criteria & T&Csvia Iboga Wellness CR
Cardiac Screening · ECG + electrolyte boardvia Iboga Wellness CR
Intake Form · health, history, intentionvia Exclusive Ibogaine

Reviewed against current clinical guidance · refreshed with each partner

The scope is honest.

A public AI in this category has to draw hard lines or it becomes something it shouldn't be. These are the three the terminal holds to without exception, and the only ones it doesn't ask permission for.

Not a clinician
It won't replace a doctor or a therapist. The partner you choose will, eventually, ask for both.
Not a decider
It won't tell you whether to do this medicine. That decision lives with you and the people who actually know you.
Not a data harvester
It won't keep your data without your consent. The free question is anonymous, and stays that way unless you sign in.

Privacy + scope · read what we keep and what we drop

Every paper, protocol, and experience.One terminal.

Peer-reviewed and clinical.

Every paper, protocol, and experience.
One terminal.